Cargando…

Efficacy and Safety of Carbon-Ion Radiotherapy for Stage I Non-Small Cell Lung Cancer with Coexisting Interstitial Lung Disease

SIMPLE SUMMARY: Interstitial lung disease (ILD) is a risk factor for lung cancer, but the treatment options are often limited because of concerns that ILD may worsen with treatment. In this study, we analyzed whether the presence or absence of ILD affects the outcome of carbon-ion radiotherapy (CIRT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okano, Naoko, Kubo, Nobuteru, Yamaguchi, Koichi, Kouno, Shunichi, Miyasaka, Yuhei, Mizukami, Tatsuji, Shirai, Katsuyuki, Saitoh, Jun-ichi, Ebara, Takeshi, Kawamura, Hidemasa, Maeno, Toshitaka, Ohno, Tatsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391416/ https://www.ncbi.nlm.nih.gov/pubmed/34439358 http://dx.doi.org/10.3390/cancers13164204

Ejemplares similares

Comparison of Oncologic Outcomes between Carbon Ion Radiotherapy and Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
por: Miyasaka, Yuhei, et al.
Publicado: (2021)

A Promising Treatment Strategy for Lung Cancer: A Combination of Radiotherapy and Immunotherapy
por: Miyasaka, Yuhei, et al.
Publicado: (2021)

Evaluation of Carbon Ion Radiation-Induced Trismus in Head and Neck Tumors Using Dose-Volume Histograms
por: Musha, Atsushi, et al.
Publicado: (2020)

Dosimetric comparison of carbon ion and X-ray radiotherapy for Stage IIIA non–small cell lung cancer
por: Kubo, Nobuteru, et al.
Publicado: (2016)

Colorectal Cancer Screening Outcomes of 2412 Prostate Cancer Patients Considered for Carbon Ion Radiotherapy
por: Kobayashi, Nao, et al.
Publicado: (2021)

Skin Dose Reduction by Layer-Stacking Irradiation in Carbon Ion Radiotherapy for Parotid Tumors
por: Kubo, Nobuteru, et al.
Publicado: (2020)

Carbon ion radiotherapy for prostate cancer with bladder invasion
por: Miyasaka, Yuhei, et al.
Publicado: (2021)

Carbon-ion Radiotherapy for Isolated Lymph Node Metastasis After Surgery or Radiotherapy for Lung Cancer
por: Shirai, Katsuyuki, et al.
Publicado: (2019)

Oral findings during follow-up of nasopharyngeal squamous cell carcinoma treatment: A case report
por: Musha, Atsushi, et al.
Publicado: (2021)

Radiotherapy for Epstein-Barr Virus-Positive Mucocutaneous Ulcer at the Lower Leg Skin: A Case Report
por: Kubo, Nobuteru, et al.
Publicado: (2022)

Hypofractionated carbon‐ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study
por: Saitoh, Jun‐ichi, et al.
Publicado: (2019)

Dose–volume constraints for head‐and‐neck cancer in carbon ion radiotherapy: A literature review
por: Varnava, Maria, et al.
Publicado: (2023)

Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”
por: Kawamura, Hidemasa, et al.
Publicado: (2020)

Efficacy of immune checkpoint inhibitor treatment for head and neck mucosal melanoma recurrence in patients treated with carbon‐ion radiotherapy
por: Musha, Atsushi, et al.
Publicado: (2023)

Cost‐effectiveness of carbon‐ion radiotherapy versus stereotactic body radiotherapy for non‐small‐cell lung cancer
por: Okazaki, Shohei, et al.
Publicado: (2021)

Prospective Study of Isolated Recurrent Tumor Re-irradiation With Carbon-Ion Beams
por: Shirai, Katsuyuki, et al.
Publicado: (2019)

Impact of Inter-fractional Anatomical Changes on Dose Distributions in Passive Carbon-Ion Radiotherapy for Prostate Cancer: Comparison of Vertical and Horizontal Fields
por: Yokoyama, Ayaka, et al.
Publicado: (2020)

Clinical results of carbon-ion radiotherapy for stage I non-small cell lung cancer with concomitant interstitial lung disease: a Japanese national registry study (J-CROS-LUNG)
por: Okano, Naoko, et al.
Publicado: (2023)

Double-layer omics analysis of castration- and X-ray-resistant prostate cancer cells
por: Iwanaga, Mototaro, et al.
Publicado: (2022)

Pilot study of aerosols visualized and evaluated in a radiotherapy room
por: Musha, Atsushi, et al.
Publicado: (2023)

Long-term outcome of hypofractionated intensity-modulated radiotherapy using TomoTherapy for localized prostate cancer: A retrospective study
por: Takakusagi, Yosuke, et al.
Publicado: (2019)

The Efficacy of Radiotherapy without Surgery for External Auditory Canal Squamous Cell Carcinoma
por: Osu, Naoto, et al.
Publicado: (2022)

Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease
por: Hagiwara, Yasuhito, et al.
Publicado: (2020)

Corrigendum to: Nationwide survey of radiation therapy in Japan for lung cancer complicated with interstitial lung disease
por: Hagiwara, Yasuhito, et al.
Publicado: (2020)

Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer—A pilot study
por: Shirai, Katsuyuki, et al.
Publicado: (2017)

Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2020)

Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
por: Matsui, Toshiaki, et al.
Publicado: (2020)

Stereotactic body radiotherapy for adenoid cystic carcinoma metastatic to the lung: a case report
por: Kobayashi, Daijiro, et al.
Publicado: (2021)

Radiotherapy Patterns of Care for Locally-advanced Non-small Cell Lung Cancer in the Pre- and Post-durvalumab Era: A Region-wide Survey in a Japanese Prefecture
por: Kubo, Nobuteru, et al.
Publicado: (2021)

Phase I dose escalation study of pemetrexed and concurrent thoracic radiation in elderly patients with non-squamous non–small-cell lung cancer
por: Kaira, Kyoichi, et al.
Publicado: (2019)

Carbon‐ion radiotherapy combined with chemotherapy for head and neck mucosal melanoma: Prospective observational study
por: Takayasu, Yukihiro, et al.
Publicado: (2019)

Managing Lung Cancer with Comorbid Interstitial Pneumonia
por: Ichihara, Eiki, et al.
Publicado: (2019)

Durable response to afatinib rechallenge in a long‐term survivor of non‐small cell lung cancer harboring EGFR L858R and L747V mutations
por: Kanbe, Mio, et al.
Publicado: (2022)

Polymyositis and fatal interstitial pneumonia following pelvic irradiation that led to unexpectedly severe adverse effects: a case report
por: Oike, Takahiro, et al.
Publicado: (2015)

Interstitial Lung Disease after Pleurodesis for Malignant Pleural Effusion
por: Yokoe, Norihito, et al.
Publicado: (2017)

Molecular Process Producing Oncogene Fusion in Lung Cancer Cells by Illegitimate Repair of DNA Double-Strand Breaks
por: Seki, Yoshitaka, et al.
Publicado: (2015)

Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy
por: Shrestha, Suman, et al.
Publicado: (2019)

Dose–volume histogram parameters of high-dose-rate brachytherapy for Stage I–II cervical cancer (≤4cm) arising from a small-sized uterus treated with a point A dose-reduced plan
por: Nakagawa, Akiko, et al.
Publicado: (2014)

Changes in Rectal Dose Due to Alterations in Beam Angles for Setup Uncertainty and Range Uncertainty in Carbon-Ion Radiotherapy for Prostate Cancer
por: Kubota, Yoshiki, et al.
Publicado: (2016)

Usual interstitial pneumonia coexisted with nonspecific interstitial pneumonia, What’s the diagnosis?
por: Fang, Xia, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_o3cc0ledoeh4jgn9oep2t4jl7v